Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization.
Teng, W
Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization. [electronic resource] - Journal of viral hepatitis 12 2017 - 1160-1167 p. digital
Publication Type: Journal Article
1365-2893
10.1111/jvh.12745 doi
Aged
Antiviral Agents--therapeutic use
Carcinoma, Hepatocellular--therapy
Chemoembolization, Therapeutic
Female
Hepatitis C, Chronic--complications
Humans
Male
Middle Aged
Recurrence
Survival Analysis
Sustained Virologic Response
Taiwan
Treatment Outcome
Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization. [electronic resource] - Journal of viral hepatitis 12 2017 - 1160-1167 p. digital
Publication Type: Journal Article
1365-2893
10.1111/jvh.12745 doi
Aged
Antiviral Agents--therapeutic use
Carcinoma, Hepatocellular--therapy
Chemoembolization, Therapeutic
Female
Hepatitis C, Chronic--complications
Humans
Male
Middle Aged
Recurrence
Survival Analysis
Sustained Virologic Response
Taiwan
Treatment Outcome